Amyloidosis, other/unspecified

DOID EFO MESH SNOMED PheWeb

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Endpoint definition

↥

FinnGen phenotype data

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 E85[8-9]

Hospital discharge: ICD-9 2773

Hospital discharge: ICD-8 27699

Cause of death: ICD-10 E85[8-9]

Cause of death: ICD-9 2773

Cause of death: ICD-8 27699

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

E4_AMYLNAS

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Amyloidosis, other/unspecified based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	232	125	107
Unadjusted prevalence (%)	0.09	0.09	0.09
Mean age at first event (years)	60.67	58.93	62.70

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Correlations

↥

Index endpoint: E4_AMYLNAS – Amyloidosis, other/unspecified
GWS hits: 6

Survival analyses between endpoints

↥

Plot

before Amyloidosis, other/unspecified
after Amyloidosis, other/unspecified

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Amyloidosis, other/unspecified

↥